Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for autoimmune, ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

Half of the survivors of bacterial meningitis experience motor deficits, seizures, hearing loss or cognitive impairment, despite adequate bacterial killing by antibiotics. We demonstrate that the ...

A new study published in the International Journal of General Medicine showed that by focusing on mast cells and inflammatory ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.

Scientists have uncovered a hidden battle between a widespread brain parasite and the immune cells tasked with destroying it. A parasite that can quietly persist in the human brain is capable of ...

When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of ...

The parasite that may already live in your brain can infect the very immune cells trying to destroy it, but new UVA Health research reveals how our bodies keep it under control.

In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...